0001752724-21-213799.txt : 20210929 0001752724-21-213799.hdr.sgml : 20210929 20210929105710 ACCESSION NUMBER: 0001752724-21-213799 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210731 FILED AS OF DATE: 20210929 PERIOD START: 20211031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALGER GLOBAL FOCUS FUND CENTRAL INDEX KEY: 0001219064 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-21308 FILM NUMBER: 211289937 BUSINESS ADDRESS: STREET 1: 360 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-806-8833 MAIL ADDRESS: STREET 1: 360 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: ALGER GLOBAL GROWTH FUND DATE OF NAME CHANGE: 20130610 FORMER COMPANY: FORMER CONFORMED NAME: ALGER CHINA-US GROWTH FUND DATE OF NAME CHANGE: 20080924 FORMER COMPANY: FORMER CONFORMED NAME: CHINA US GROWTH FUND DATE OF NAME CHANGE: 20040121 0001219064 S000009192 ALGER GLOBAL FOCUS FUND C000024981 ALGER GLOBAL FOCUS FUND CLASS A CHUSX C000060632 ALGER GLOBAL FOCUS FUND CLASS C CHUCX C000127110 ALGER GLOBAL FOCUS FUND CLASS I AFGIX C000127111 ALGER GLOBAL FOCUS FUND CLASS Z AFGZX NPORT-P 1 primary_doc.xml NPORT-P false 0001219064 XXXXXXXX S000009192 C000024981 C000127111 C000060632 C000127110 Alger Global Focus Fund 811-21308 0001219064 5493000R8VYGCU6Y1832 360 Park Avenue South NULL New York 10010 212-806-8833 Alger Global Focus Fund S000009192 5493000R8VYGCU6Y1832 2021-10-31 2021-07-31 N 34138471.42 143120.97 33995350.45 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 265114.83000000 N ADYEN NV /EUR/ 724500973ODKK3IFQ447 ADYEN NV /EUR/ 144A 0.00000000 N3501V104 290.00000000 NS 785881.83000000 2.311733279984 Long EC CORP NL Y 2 N N N PRO MEDICUS LTD /AUD/ N/A PRO MEDICUS LTD /AUD/ 0.00000000 Q77301101 11700.00000000 NS 500142.66000000 1.471209013525 Long EC CORP AU N 2 N N N HOYA CORP /JPY/ 353800X4VR3BHEUCJB42 HOYA CORP /JPY/ 0.00000000 J22848105 5100.00000000 NS 719965.13000000 2.117834116929 Long EC CORP JP N 2 N N N GRIFOLS SA-ADR 959800HSSNXWRKBK4N60 GRIFOLS SA-ADR 0.00000000 398438408 35997.00000000 NS USD 547514.37000000 1.610556628340 Long EC CORP ES N 1 N N N AMAZON.COM INC ZXTILKJKG63JELOEG630 AMAZON.COM INC 0.00000000 023135106 490.00000000 NS USD 1630519.10000000 4.796300312885 Long EC CORP US N 1 N N N MICROSOFT CORP INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 0.00000000 594918104 6900.00000000 NS USD 1965879.00000000 5.782787863567 Long EC CORP US N 1 N N N VERBIO VEREINIGTE BIOENE /EUR/ 529900W51PINCFFALS96 VERBIO VEREINIGTE BIOENERGI /EUR/ 0.00000000 D86145105 13318.00000000 NS 721408.83000000 2.122080874150 Long EC CORP DE N 2 N N N CORE LABORATORIES N.V. 724500MDYY5VBSAF5W50 CORE LABORATORIES N.V. 0.00000000 N22717107 18100.00000000 NS USD 603816.00000000 1.776172305939 Long EC CORP NL N 1 N N N VISA INC-CLASS A SHARES 549300JZ4OKEHW3DPJ59 VISA INC-CLASS A SHARES 0.00000000 92826C839 3700.00000000 NS USD 911643.00000000 2.681669663446 Long EC CORP US N 1 N N N ADOBE INC FU4LY2G4933NH2E1CP29 ADOBE INC 0.00000000 00724F101 1893.00000000 NS USD 1176745.59000000 3.461489804997 Long EC CORP US N 1 N N N AKER CARBON CAPTURE ASA /NOK/ 549300JXF011KX2HXT02 AKER CARBON CAPTURE ASA /NOK/ 0.00000000 R00762113 252219.00000000 NS 558556.90000000 1.643039099777 Long EC CORP NO N 2 N N N INTUIT INC VI90HBPH7XSFMB9E4M29 INTUIT INC 0.00000000 461202103 2150.00000000 NS USD 1139435.50000000 3.351739237622 Long EC CORP US N 1 N N N SCHLUMBERGER LTD 213800ZUA17OK3QLGM62 SCHLUMBERGER LTD 0.00000000 806857108 21800.00000000 NS USD 628494.00000000 1.848764585981 Long EC CORP US N 1 N N N AUTODESK INC FRKKVKAIQEF3FCSTPG55 AUTODESK INC 0.00000000 052769106 2825.00000000 NS USD 907192.25000000 2.668577431888 Long EC CORP US N 1 N N N POLYPEPTIDE GROUP AG /CHF/ N/A POLYPEPTIDE GROUP AG /CHF/ 144A 0.00000000 H6306W109 5244.00000000 NS 571606.65000000 1.681425966885 Long EC CORP CH Y 2 N N N PROSETTA BIOSCIENCES INC. /PFD N/A PROSETTA BIOSCIENCES INC. SERIES D PREFERRED 0.00000000 N/A 33858.00000000 NS USD 5078.70000000 0.014939395925 Long EP CORP US Y 3 N N N MONCLER SPA /EUR/ 815600EBD7FB00525B20 MONCLER SPA /EUR/ 0.00000000 T6730E110 15353.00000000 NS 1054441.46000000 3.101722576888 Long EC CORP IT N 2 N N N TELEPERFORMANCE /EUR/ 9695004GI61FHFFNRG61 TELEPERFORMANCE /EUR/ 0.00000000 F9120F106 2175.00000000 NS 917369.52000000 2.698514672908 Long EC CORP FR N 2 N N N ALFEN BEHEER B.V. /EUR/ 724500HDW6IWR9J5YT90 ALFEN BEHEER B.V. /EUR/ 144A 0.00000000 N0227W101 9400.00000000 NS 947984.18000000 2.788570105768 Long EC CORP NL Y 2 N N N EUROFINS SCIENTIFIC /EUR/ 529900JEHFM47DYY3S57 EUROFINS SCIENTIFIC /EUR/ 0.00000000 L31839134 8100.00000000 NS 968820.12000000 2.849860663813 Long EC CORP LU N 2 N N N KERRY GROUP PLC-A /EUR/ 635400TLVVBNXLFHWC59 KERRY GROUP PLC-A /EUR/ 0.00000000 G52416107 5450.00000000 NS 807506.96000000 2.375345302551 Long EC CORP IE N 2 N N N PRADA S.P.A. /HKD/ N/A PRADA S.P.A. /HKD/ 0.00000000 T7733C101 101500.00000000 NS 795342.32000000 2.339562056198 Long EC CORP IT N 2 N N N FISERV INC GI7UBEJLXYLGR2C7GV83 FISERV INC 0.00000000 337738108 4600.00000000 NS USD 529506.00000000 1.557583590081 Long EC CORP US N 1 N N N FREEPORT-MCMORAN INC 549300IRDTHJQ1PVET45 FREEPORT-MCMORAN INC 0.00000000 35671D857 24000.00000000 NS USD 914400.00000000 2.689779596021 Long EC CORP US N 1 N N N SIKA AG-REG /CHF/ 549300R3N69ECGYPU434 SIKA AG-REG /CHF/ 0.00000000 H7631K273 2600.00000000 NS 915852.88000000 2.694053356934 Long EC CORP CH N 2 N N N LVMH MOET HENNESSY LOUIS /EUR/ IOG4E947OATN0KJYSD45 LVMH MOET HENNESSY LOUIS VUI /EUR/ 0.00000000 F58485115 1285.00000000 NS 1028814.16000000 3.026337856152 Long EC CORP FR N 2 N N N XERO LTD /AUD/ 254900UG5D8YST164N14 XERO LTD /AUD/ 0.00000000 Q98665104 7450.00000000 NS 772954.96000000 2.273707874071 Long EC CORP NZ N 2 N N N LASERTEC CORP /JPY/ N/A LASERTEC CORP /JPY/ 0.00000000 J38702106 2000.00000000 NS 375463.48000000 1.104455388839 Long EC CORP JP N 2 N N N FERRARI NV 549300RIVY5EX8RCON76 FERRARI NV 0.00000000 N3167Y103 4150.00000000 NS USD 905903.50000000 2.664786472292 Long EC CORP IT N 1 N N N WIZZ AIR HOLDINGS PLC /GBP/ 213800COXGZCORLJZA85 WIZZ AIR HOLDINGS PLC /GBP/ 144A 0.00000000 G96871101 9750.00000000 NS 670091.02000000 1.971125495486 Long EC CORP CH Y 2 N N N MERCADOLIBRE INC 549300DKPDN9M5S8GB14 MERCADOLIBRE INC 0.00000000 58733R102 325.00000000 NS USD 509827.50000000 1.499697732929 Long EC CORP AR N 1 N N N BYD CO LTD-H /HKD/ 5299005557VL7ULJ7A69 BYD CO LTD-H /HKD/ 0.00000000 Y1023R104 27400.00000000 NS 846907.83000000 2.491246063915 Long EC CORP CN N 2 N N N CROWDSTRIKE HOLDINGS INC - A 549300YBY08K9KM4HX32 CROWDSTRIKE HOLDINGS INC - A 0.00000000 22788C105 3850.00000000 NS USD 976398.50000000 2.872153065273 Long EC CORP US N 1 N N N MSCI INC 549300HTIN2PD78UB763 MSCI INC 0.00000000 55354G100 1900.00000000 NS USD 1132324.00000000 3.330820200443 Long EC CORP US N 1 N N N NVIDIA CORP 549300S4KLFTLO7GSQ80 NVIDIA CORP 0.00000000 67066G104 6000.00000000 NS USD 1169940.00000000 3.441470626169 Long EC CORP US N 1 N N N FANUC CORPORATION /JPY/ 529900QTSW745LOKW705 FANUC CORPORATION /JPY/ 0.00000000 J13440102 3600.00000000 NS 806283.87000000 2.371747487015 Long EC CORP JP N 2 N N N SAMSONITE INTERNATIONAL /HKD/ 549300UULS5HYFJSEL12 SAMSONITE INTERNATIONAL SA /HKD/ 144A 0.00000000 L80308106 430483.00000000 NS 801273.06000000 2.357007794870 Long EC CORP US Y 2 N N N INSULET CORP 549300TZTYD2PYN92D43 INSULET CORP 0.00000000 45784P101 3150.00000000 NS USD 881023.50000000 2.591599993345 Long EC CORP US N 1 N N N MURATA MANUFACTURING CO /JPY/ 529900QZG6DL8ZRI7140 MURATA MANUFACTURING CO LTD /JPY/ 0.00000000 J46840104 8500.00000000 NS 705378.66000000 2.074926866947 Long EC CORP JP N 2 N N N NEXI SPA /EUR/ 5493000P70CQRQG8SN85 NEXI SPA /EUR/ 144A 0.00000000 T6S18J104 30800.00000000 NS 659871.30000000 1.941063384448 Long EC CORP IT Y 2 N N N 2021-08-30 Alger Global Focus Fund Anthony Caputo Anthony Caputo Assistant Treasurer XXXX NPORT-EX 2 brhc10029161_algerglobalff.htm SOI


ALGER GLOBAL
FOCUS FUND

QUARTERLY REPORT
JULY 31, 2021


ALGER GLOBAL FOCUS FUND
Schedule of Investments July 31, 2021 (Unaudited)

COMMON STOCKS—98.4%
 
SHARES
   
VALUE
 
ARGENTINA—1.5%
           
INTERNET & DIRECT MARKETING RETAIL—1.5%
           
MercadoLibre, Inc.*
   
325
   
$
509,827
 
(Cost $522,472)
               
AUSTRALIA—3.7%
               
APPLICATION SOFTWARE—2.3%
               
Xero Ltd.*
   
7,450
     
772,955
 
HEALTHCARE TECHNOLOGY—1.4%
               
Pro Medicus Ltd.
   
11,700
     
500,143
 
TOTAL AUSTRALIA
               
(Cost $751,453)
            1,273,098  
CHINA—2.5%
               
AUTOMOBILE MANUFACTURERS—2.5%
               
BYD Co., Ltd., Cl. H
   
27,400
     
846,908
 
(Cost $639,069)
               
FRANCE—8.6%
               
APPAREL ACCESSORIES & LUXURY GOODS—3.0%
               
LVMH Moet Hennessy Louis Vuitton SE
   
1,285
     
1,028,814
 
LIFE SCIENCES TOOLS & SERVICES—2.9%
               
Eurofins Scientific SE
   
8,100
     
968,820
 
RESEARCH & CONSULTING SERVICES—2.7%
               
Teleperformance
   
2,175
     
917,370
 
TOTAL FRANCE
               
(Cost $1,469,772)
           
2,915,004
 
GERMANY—2.1%
               
OIL & GAS REFINING & MARKETING—2.1%
               
VERBIO Vereinigte BioEnergie AG
   
13,318
     
721,409
 
(Cost $645,523)
               
HONG KONG—2.3%
               
APPAREL ACCESSORIES & LUXURY GOODS—2.3%
               
Samsonite International SA*
   
430,483
     
801,273
 
(Cost $468,119)
               
HUNGARY—2.0%
               
AIRLINES—2.0%
               
Wizz Air Holdings PLC*
   
9,750
     
670,091
 
(Cost $635,453)
               
IRELAND—2.4%
               
PACKAGED FOODS & MEATS—2.4%
               
Kerry Group PLC, Cl. A
   
5,450
     
807,507
 
(Cost $642,123)
               
ITALY—10.0%
               
APPAREL ACCESSORIES & LUXURY GOODS—5.4%
               
Moncler SpA
   
15,353
     
1,054,442
 
PRADA SpA
   
101,500
     
795,342
 
             
1,849,784
 
AUTOMOBILE MANUFACTURERS—2.7%
               
Ferrari NV
   
4,150
     
905,904
 

-2-

ALGER GLOBAL FOCUS FUND
Schedule of Investments July 31, 2021 (Unaudited) (Continued)
 
COMMON STOCKS—98.4% (CONT.)
 
SHARES
   
VALUE
 
ITALY—10.0% (CONT.)
           
DATA PROCESSING & OUTSOURCED SERVICES—1.9%
           
Nexi SpA*
   
30,800
   
$
659,871
 
TOTAL ITALY
               
(Cost $2,724,850)
           
3,415,559
 
JAPAN—7.7%
               
ELECTRONIC COMPONENTS—2.1%
               
Murata Manufacturing Co., Ltd.
   
8,500
     
705,379
 
HEALTHCARE SUPPLIES—2.1%
               
Hoya Corp.
   
5,100
     
719,965
 
INDUSTRIAL MACHINERY—2.4%
               
FANUC Corp.
   
3,600
     
806,284
 
SEMICONDUCTOR EQUIPMENT—1.1%
               
Lasertec Corp.
   
2,000
     
375,463
 
TOTAL JAPAN
               
(Cost $2,300,547)
           
2,607,091
 
NETHERLANDS—6.9%
               
DATA PROCESSING & OUTSOURCED SERVICES—2.3%
               
Adyen NV*
   
290
     
785,882
 
HEAVY ELECTRICAL EQUIPMENT—2.8%
               
Alfen Beheer BV*
   
9,400
     
947,984
 
OIL & GAS EQUIPMENT & SERVICES—1.8%
               
Core Laboratories NV
   
18,100
     
603,816
 
TOTAL NETHERLANDS
               
(Cost $1,634,875)
           
2,337,682
 
NORWAY—1.6%
               
ENVIRONMENTAL & FACILITIES SERVICES—1.6%
               
Aker Carbon Capture ASA*
   
252,219
     
558,557
 
(Cost $584,158)
               
SPAIN—1.6%
               
BIOTECHNOLOGY—1.6%
               
Grifols SA#
   
35,997
     
547,514
 
(Cost $721,008)
               
SWITZERLAND—4.4%
               
LIFE SCIENCES TOOLS & SERVICES—1.7%
               
PolyPeptide Group AG*
   
5,244
     
571,606
 
SPECIALTY CHEMICALS—2.7%
               
Sika AG
   
2,600
     
915,853
 
TOTAL SWITZERLAND
               
(Cost $963,670)
           
1,487,459
 
UNITED STATES—41.1%
               
APPLICATION SOFTWARE—9.5%
               
Adobe, Inc.*
   
1,893
     
1,176,746
 
Autodesk, Inc.*
   
2,825
     
907,192
 
Intuit, Inc.
   
2,150
     
1,139,435
 
             
3,223,373
 

-3-

ALGER GLOBAL FOCUS FUND
Schedule of Investments July 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—98.4% (CONT.)
 
SHARES
   
VALUE
 
UNITED STATES—41.1% (CONT.)
           
COPPER—2.7%
           
Freeport-McMoRan, Inc.
   
24,000
   
$
914,400
 
DATA PROCESSING & OUTSOURCED SERVICES—4.2%
               
Fiserv, Inc.*
   
4,600
     
529,506
 
Visa, Inc., Cl. A
   
3,700
     
911,643
 
             
1,441,149
 
FINANCIAL EXCHANGES & DATA—3.3%
               
MSCI, Inc., Cl. A
   
1,900
     
1,132,324
 
HEALTHCARE EQUIPMENT—2.6%
               
Insulet Corp.*
   
3,150
     
881,024
 
INTERNET & DIRECT MARKETING RETAIL—4.8%
               
Amazon.com, Inc.*
   
490
     
1,630,519
 
OIL & GAS EQUIPMENT & SERVICES—1.9%
               
Schlumberger NV
   
21,800
     
628,494
 
SEMICONDUCTORS—3.4%
               
NVIDIA Corp.
   
6,000
     
1,169,940
 
SYSTEMS SOFTWARE—8.7%
               
Crowdstrike Holdings, Inc., Cl. A*
   
3,850
     
976,398
 
Microsoft Corp.
   
6,900
     
1,965,879
 
             
2,942,277
 
TOTAL UNITED STATES
               
(Cost $9,098,764)
           
13,963,500
 
TOTAL COMMON STOCKS
               
(Cost $23,801,856)
           
33,462,479
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
UNITED STATES—0.0%
               
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
33,858
     
5,079
 
(Cost $152,361)
               
Total Investments
               
(Cost $23,954,217)
   
98.4
%
 
$
33,467,558
 
Affiliated Securities (Cost $152,361)
           
5,079
 
Unaffiliated Securities (Cost $23,801,856)
           
33,462,479
 
Other Assets in Excess of Liabilities
   
1.6
%
   
531,153
 
NET ASSETS
   
100.0
%
 
$
33,998,711
 

#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
*
Non-income producing security.

-4-

ALGER GLOBAL FOCUS FUND
Schedule of Investments July 31, 2021 (Unaudited) (Continued)
 
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
Security
Acquisition
Date(s)
 
Acquisition
Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
7/31/2021
 
Prosetta Biosciences, Inc., Series D
2/6/15
 
$
152,361
     
0.40
%
 
$
5,079
     
0.01
%
Total
                   
$
5,079
     
0.01
%
 
See Notes to Financial Statements.

-5-

ALGER GLOBAL FOCUS FUND
NOTES TO FINANCIAL STATEMENTS (Unaudited)

NOTE 1 — General:

Alger Global Focus Fund (the “Fund”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Fund qualifies as an investment company as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 946-Financial Services – Investment Companies. The Fund’s investment objective is long-term capital appreciation. It seeks to achieve its objective by investing in equity securities in the United States and foreign countries. The Fund’s foreign investments will include securities of companies in both developed and emerging market countries. The Fund offers Class A, C, I and Z shares. Class A shares are generally subject to an initial sales charge while Class C shares are generally subject to a deferred sales charge. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the eighth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may not convert to Class A shares or may be converted on a different schedule. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Effective August 27, 2019, Class C shares were closed to direct shareholders and are only available for purchase through certain financial intermediaries and group retirement plan recordkeeping platforms. Class I shares are sold to institutional investors without an initial or deferred sales charge and Class Z Shares are generally subject to a minimum initial investment of $500,000. Each class has identical rights to assets and earnings, except that each share class bears the pro rata allocation of a Fund’s expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).
 
NOTE 2 — Significant Accounting Policies:

(a) Investment Valuation: The Fund values its financial instruments at fair value using independent dealers or pricing services under policies approved by the Fund’s Board of Trustees (the “Board”). Investments held by the Fund are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern Time).
 
Investments in money market funds and short-term securities held by the Fund having a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available, are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.

-6-

ALGER GLOBAL FOCUS FUND
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
Debt securities generally trade in the over-the-counter market. Debt securities with remaining maturities of more than sixty days at the time of acquisition are valued on the basis of the last available bid prices or current market quotations provided by dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrixes, market transactions in comparable investments, various relationships observed in the market between investments and calculated yield measures based on valuation technology commonly employed in the market for such investments. Asset-backed and mortgage-backed securities are valued by independent pricing services using models that consider estimated cash flows of each tranche of the security, establish a benchmark yield and develop an estimated tranche-specific spread to the benchmark yield based on the unique attributes of the tranche. Debt securities with a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Securities for which market quotations are not readily available are valued at fair value, as determined in good faith pursuant to procedures established by the Board and described further herein.
 
Securities in which the Fund invests may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the Fund’s investment adviser, pursuant to policies established by the Board, believes to be the fair value of these securities as of the close of the NYSE. The Fund may also fair value securities in other situations, for example, when a particular foreign market is closed but the Fund is open.
 
FASB Accounting Standards Codification 820 – Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Fund would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Fund. Unobservable inputs are inputs that reflect the Fund’s own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.


Level 1 – quoted prices in active markets for identical investments
 

Level 2 – significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
 

Level 3 – significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

-7-

ALGER GLOBAL FOCUS FUND
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
The Fund’s valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market transactions involving identical or comparable assets to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization (“EBITDA”) multiples, discount rates, time to exit and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company’s financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the valuations assigned to such securities by the Fund may significantly differ from the valuations that would have been assigned by the Fund had there been an active market for such securities.
 
Valuation processes are determined by a Valuation Committee (“Committee”) authorized by the Board and comprised of representatives of the Fund’s investment adviser and officers of the Fund. The Committee reports its fair valuation determinations and related valuation information to the Board. The Board is responsible for approving the valuation policy and procedures.
 
While the Committee meets on an as-needed basis, the Committee generally meets quarterly to review and evaluate the effectiveness of the procedures for making fair value determinations. The Committee considers, among other things, the results of quarterly back testing of the fair value model for foreign securities, pricing comparisons between primary and secondary price sources, the outcome of price challenges put to the Fund’s pricing vendor, and variances between transactional prices and the previous day’s price.
 
(b) Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars, foreign cash and overnight time deposits.
 
NOTE 3 — Fair Value Measurements:

The following is a summary of the inputs used as of July 31, 2021 in valuing the Fund’s investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with its investments, the Fund has determined that presenting them by security type and sector is appropriate.

-8-

ALGER GLOBAL FOCUS FUND
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Global Focus Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Consumer Discretionary
 
$
7,573,029
   
$
3,046,250
   
$
4,526,779
   
$
 
Consumer Staples
   
807,507
     
     
807,507
     
 
Energy
   
1,953,719
     
1,232,310
     
721,409
     
 
Financials
   
1,132,324
     
1,132,324
     
     
 
Healthcare
   
4,189,072
     
1,428,538
     
2,760,534
     
 
Industrials
   
3,900,286
     
     
3,900,286
     
 
Information Technology
   
12,076,289
     
8,776,739
     
3,299,550
     
 
Materials
   
1,830,253
     
914,400
     
915,853
     
 
TOTAL COMMON STOCKS
 
$
33,462,479
   
$
16,530,561
   
$
16,931,918
   
$
 
PREFERRED STOCKS
                               
Healthcare
   
5,079
     
     
     
5,079
 
TOTAL INVESTMENTS IN SECURITIES
 
$
33,467,558
   
$
16,530,561
   
$
16,931,918
   
$
5,079
 
 

 
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Global Focus Fund
 
Preferred Stocks
 
Opening balance at November 1, 2020
 
$
5,079
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at July 31, 2021
   
5,079
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2021
 
$
 
 
The following table provides quantitative information about the Fund’s Level 3 fair value measurements of the Fund’s investments as of July 31, 2021. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to the Fund’s fair value measurements.

   
Fair Value
July 31, 2021
 
Valuation
Methodology
Unobservable
Input
 
Range/Input
   
Weighted
Average Inputs
 
Alger Global Focus Fund
                     
Preferred Stocks
 
$
5,079
 
Income
Approach
Discount Rate
   
72.50%-77.50
%
   
N/A
 

-9-

ALGER GLOBAL FOCUS FUND
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
The significant unobservable inputs used in the fair value measurement of the Fund’s securities are revenue and EBITDA multiples, discount rates, and the probabilities of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between these inputs would have resulted in significantly higher or lower fair value measurements than those noted in the table above. Generally, all other things being equal, increases in revenue and EBITDA multiples, decreases in discount rates, and increases in the probabilities of success result in higher fair value measurements, whereas decreases in revenues and EBITDA multiples, increases in discount rates, and decreases in the probabilities of success result in lower fair value measurements.
 
Certain of the Fund’s assets and liabilities are held at carrying amount or face value, which approximates fair value for financial statements purposes. As of July 31, 2021, such assets were categorized within the ASC 820 disclosure hierarchy as follows:
 
   
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
Cash, foreign cash and cash equivalents
 
$
527,952
   
$
527,952
   
$
   
$
 
 
NOTE 4 — Derivatives:

FASB Accounting Standards Codification 815 – Derivatives and Hedging (“ASC 815”) requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.
 
Forward foreign currency contracts - In connection with portfolio purchases and sales of securities denominated in foreign currencies, the Fund may enter into forward foreign currency contracts. Additionally, the Fund may enter into such contracts to economically hedge certain other foreign currency denominated investments. These contracts are valued at the current cost of covering or offsetting such contracts. In the event that counterparties fail to settle these currency contracts or the related foreign security trades, the Fund could be exposed to foreign currency fluctuation.
 
NOTE 5 — Affiliated Securities:

The issuers of the securities listed below are deemed to be affiliates of the Fund because the Fund or its affiliates owned 5% or more of the issuer’s voting securities during all or part of the period ended July 31, 2021. Information regarding the Fund’s holdings of such securities is set forth in the following table:
 
Security
 
Value at
October 31,
2020
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
in
Unrealized
App(Dep)
   
Value at
July 31,
2021
 
Alger Global Focus Fund
                                         
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
5,079
   
$
   
$
   
$
   
$
   
$
   
$
5,079
 
Total
 
$
5,079
   
$
   
$
   
$
   
$
   
$
   
$
5,079
 
 

-10-